Opdivo trial offers new insights into how immuno-oncology drugs could be enhanced – FierceBiotech

Despite the success of checkpoint inhibitors that remove the blockade that cancer cells impose on the immune system, the drugs only work in some patients. A research team led by scientists at the Uni…
Read More